CN106860505A - A kind of medicine for preventing and treating porcine contagious pleuropneumonia - Google Patents

A kind of medicine for preventing and treating porcine contagious pleuropneumonia Download PDF

Info

Publication number
CN106860505A
CN106860505A CN201710029220.0A CN201710029220A CN106860505A CN 106860505 A CN106860505 A CN 106860505A CN 201710029220 A CN201710029220 A CN 201710029220A CN 106860505 A CN106860505 A CN 106860505A
Authority
CN
China
Prior art keywords
medicine
contagious pleuropneumonia
porcine contagious
extract
asafoetide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201710029220.0A
Other languages
Chinese (zh)
Inventor
何声武
程贤防
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Anhui Tian'an Biological Technology Co Ltd
Original Assignee
Anhui Tian'an Biological Technology Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anhui Tian'an Biological Technology Co Ltd filed Critical Anhui Tian'an Biological Technology Co Ltd
Priority to CN201710029220.0A priority Critical patent/CN106860505A/en
Publication of CN106860505A publication Critical patent/CN106860505A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/01Hydrocarbons
    • A61K31/015Hydrocarbons carbocyclic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/60Salicylic acid; Derivatives thereof
    • A61K31/612Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
    • A61K31/616Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716Glucans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/06Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/06Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/10Carbonates; Bicarbonates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56Materials from animals other than mammals
    • A61K35/57Birds; Materials from birds, e.g. eggs, feathers, egg white, egg yolk or endothelium corneum gigeriae galli
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06Fungi, e.g. yeasts
    • A61K36/062Ascomycota
    • A61K36/064Saccharomycetales, e.g. baker's yeast
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/23Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/33Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/331Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

The invention mainly relates to cultural technique field, a kind of medicine for preventing and treating porcine contagious pleuropneumonia is disclosed, be made up of following raw material:Egg shell, tip or stalactite, marmor serpentinatum, Tilmicosin pre-mixing agent, florfenicol powder, Carbaspirin calcium powder, asafoetide extract, peanut coat extract, lentinan, beta glucan, elemene, glycine betaine, brewer's yeast;There is preferable prevention effect to porcine contagious pleuropneumonia, the incidence of porcine contagious pleuropneumonia is down to 0%, cure rate reaches 98%, reduces the use of antibiotic, saves aquaculture cost, the income of cultivation peasant household is improved 11.4%;Medicine adds egg shell, is extracted together with tip or stalactite and marmor serpentinatum, increases multiple nutritional components, promote absorption of the pig to nutrient, improve the resistance against diseases of pig, reduce the generation of various diseases, the quality and mouthfeel of pork are improved, increases the income of raiser.

Description

A kind of medicine for preventing and treating porcine contagious pleuropneumonia
Technical field
The invention mainly relates to cultural technique field, more particularly to a kind of medicine for preventing and treating porcine contagious pleuropneumonia.
Background technology
Porcine contagious pleuropneumonia is a kind of highly infectious breathing problem for causing pig by Actinobacillus pleuropneumoniae, It is characterized with acute hemorrhagic cellulosic pleuropneumonia and chronic fibro disposition necrotizing pleuropneumonia, is a kind of worldwide disease Disease, acute to break out swinery, morbidity and mortality are generally 50% or so, and the death rate of most acute is given up to 80~100% Cultivation peasant household causes very big economic loss.
Current porcine contagious pleuropneumonia is treated using antibiotic mostly, it is impossible to play prevention effect, substantial amounts of anti- Raw element easily makes germ develop immunity to drugs, and therapeutic effect is gradually deteriorated, and residual can be also caused in pig body, influences pork quality, Harm can also be produced to human body.
The content of the invention
In order to make up the defect of prior art, it is an object of the invention to provide a kind of medicine for preventing and treating porcine contagious pleuropneumonia Thing.
A kind of medicine for preventing and treating porcine contagious pleuropneumonia, is made up of the raw material of following weight portion:Egg shell 72 ~ 74, goose Pipe stone 56 ~ 58, marmor serpentinatum 51 ~ 53, Tilmicosin pre-mixing agent 2.4 ~ 2.6, florfenicol powder 2.1 ~ 2.3, Carbaspirin calcium powder 2.1 ~ 2.3, asafoetide extract 1.6 ~ 1.8, peanut coat extract 1.6 ~ 1.8, lentinan 0.23 ~ 0.25, beta glucan 0.23 ~ 0.25th, elemene 0.07 ~ 0.09, glycine betaine 0.06 ~ 0.08, brewer's yeast 3 ~ 5.
Described egg shell, is the egg shell of generation after green shell hatching of breeding eggs.
Described asafoetide extract, asafoetide is crushed to, and is placed in temperature for 40 ~ 45 DEG C, mass concentration are 1.3 ~ 1.5% Soaked 30 ~ 40 minutes in edible alkali solution, remove stink, cleaned with clear water, add 70 ~ 80 times of water of amount of asafoetide weight, heating It is original 1/20 to be concentrated into volume, crosses and filters precipitation, and it is 4 ~ 6% that filtrate is dried to water content, obtains asafoetide extract.
Described peanut coat extract, peanut coat is fried to burnt odor, adds 60 ~ 70 times of volume fractions of amount of peanut coat weight It is 3 ~ 4% acetum, in 32 ~ 34kHz ultrasounds 40 ~ 50 minutes, heating was boiled, and it is original 1/15 to be concentrated into volume, filtering It is 7 ~ 9% by freeze-drying to water content except precipitation, obtains peanut coat extract.
Described lentinan, purity is 96 ~ 100%.
Described brewer's yeast, activated, viable count is 109~1010CFU/ml。
A kind of preparation method of the medicine for preventing and treating porcine contagious pleuropneumonia, specifically includes following steps:
(1)Egg shell is crushed, 80 ~ 90 DEG C is placed in and is stir-fried 10 ~ 15 minutes, obtain stir-fry egg-shell meal;
(2)Tip or stalactite and marmor serpentinatum are crushed to 80 ~ 100 mesh, in after 160 ~ 170 DEG C of calcinations 12 ~ 14 minutes, goose pipe are added immediately 3 ~ 4 times of temperature of amount of stone weight are 1 ~ 10 DEG C of water, are stirred, and naturally cool to room temperature, obtain stone flour slurry;
(3)Egg-shell meal will be fried and add stone flour slurry, be slowly added to the vinegar that 100 ~ 120 times of volume fractions of amount of egg shell weight are for 7 ~ 9% Acid solution, in 40 ~ 45 DEG C, 36 ~ 38kHz ultrasounds 20 ~ 25 minutes, heating boils that to be concentrated into volume be original 1/15, increases various Nutritional ingredient, promotes absorption of the pig to nutrient, improves the resistance against diseases of pig, reduces the generation of various diseases, and filtering must be carried Take liquid;
(4)Asafoetide extract and peanut coat extract are added into extract solution, is well mixed, add brewer's yeast, it is quiet in 20 ~ 22 DEG C Put fermentation 3 ~ 4 days, promote each composition fusion, improve the performance of drug effect, be heated to 60 ~ 70 DEG C, be incubated 25 ~ 30 minutes, must ferment Liquid;
(5)Lentinan, beta glucan, elemene and glycine betaine are added into zymotic fluid, is stirred to being completely dissolved, freeze-drying is extremely Water content is 8 ~ 10%, obtains mixed powder;
(6)Tilmicosin pre-mixing agent, florfenicol powder and Carbaspirin calcium powder are added into mixed powder, effect complements each other, promoted The performance of each composition drug effect, can provide nutrition, also can antibacterial sterilization, kill pathogenic microorganism, strengthen pig resistance against diseases, keep away Exempt to develop immunity to drugs antibiotic and antibiotic residue, improve the quality and mouthfeel of pork, be well mixed, obtain preventing and treating pig transmissible The medicine of pleuropneumonia;
(7)Vacuum packaging, inspection, obtains finished product.
The application method of the medicine of the preventing and treating porcine contagious pleuropneumonia, will prevent and treat the medicine of porcine contagious pleuropneumonia Pig feed is added, is well mixed, addition is the piglet at 0.3 ~ 0.4%, 2 weeks ~ 7 monthly ages of pig feed weight, every 2 ~ 3 days Addition once, August and the pig after August age, addition in every 4 ~ 5 days is once.
It is an advantage of the invention that:The medicine of a kind of preventing and treating porcine contagious pleuropneumonia that the present invention is provided, to pig transmissible Pleuropneumonia has preferable prevention effect, the incidence of porcine contagious pleuropneumonia is down to 0%, and cure rate reaches 98%, subtracts The use of few antibiotic, saves aquaculture cost, the income of cultivation peasant household is improved 11.4%;Medicine adds egg shell, with goose Guan Shi and marmor serpentinatum are extracted repeatedly together, and recovery rate improves 27.3%, increase multiple nutritional components, promote pig to nutrition unit The absorption of element, improves the resistance against diseases of pig, reduces the generation of various diseases;Various plants extract is added, with a small amount of antibiotic Compatibility, effect complements each other, and promotes the performance of each composition drug effect, can provide nutrition, also can antibacterial sterilization, the killing micro- life of cause of disease Thing, strengthens the resistance against diseases of pig, reduces the generation of porcine contagious pleuropneumonia, it is to avoid antibiotic is developed immunity to drugs and antibiotic Residual, improves the quality and mouthfeel of pork, increases the income of raiser.
Specific embodiment
Below the present invention is illustrated with specific embodiment.
Embodiment 1
A kind of medicine for preventing and treating porcine contagious pleuropneumonia, is made up of the raw material of following weight portion:Egg shell 72, tip or stalactite 56, Marmor serpentinatum 51, Tilmicosin pre-mixing agent 2.4, florfenicol powder 2.1, Carbaspirin calcium powder 2.1, asafoetide extract 1.6, peanut coat Extract 1.6, lentinan 0.23, beta glucan 0.23, elemene 0.07, glycine betaine 0.06, brewer's yeast 3.
Described egg shell, is the egg shell of generation after green shell hatching of breeding eggs.
Described asafoetide extract, asafoetide is crushed to, be placed in temperature for 40 ~ 45 DEG C, mass concentration be 1.3% it is edible Soaked 30 minutes in aqueous slkali, remove stink, cleaned with clear water, add 70 times of water of amount of asafoetide weight, heating is concentrated into volume It is original 1/20, crosses and filter precipitation, it is 4 ~ 6% that filtrate is dried to water content, obtains asafoetide extract.
Described peanut coat extract, peanut coat is fried to burnt odor, and the volume fraction for adding 60 times of amounts of peanut coat weight is 3% acetum, ultrasonic 40 minutes in 32kHz, heating is boiled, and it is original 1/15 to be concentrated into volume, is crossed and is filtered precipitation, will Freeze-drying to water content is 7 ~ 9%, obtains peanut coat extract.
Described lentinan, purity is 96 ~ 100%.
Described brewer's yeast, activated, viable count is 109~1010CFU/ml。
A kind of preparation method of the medicine for preventing and treating porcine contagious pleuropneumonia, specifically includes following steps:
(1)Egg shell is crushed, 80 ~ 90 DEG C is placed in and is stir-fried 15 minutes, obtain stir-fry egg-shell meal;
(2)Tip or stalactite and marmor serpentinatum are crushed to 80 mesh, in after 170 DEG C of calcinations 14 minutes, adding 4 times of amounts of tip or stalactite weight immediately Temperature be 5 DEG C of water, stir, naturally cool to room temperature, obtain stone flour slurry;
(3)Egg-shell meal will be fried and add stone flour slurry, be slowly added to the acetic acid that 120 times of volume fractions measured of egg shell weight are 9% molten Liquid, in 45 DEG C, 36kHz ultrasounds 25 minutes, heating is boiled and is concentrated into volume for original 1/15, increases multiple nutritional components, is promoted Absorption of the pig to nutrient, improves the resistance against diseases of pig, reduces the generation of various diseases, and filtering obtains extract solution;
(4)Asafoetide extract and peanut coat extract are added into extract solution, is well mixed, add brewer's yeast, in 22 DEG C of standings Fermentation 4 days, promotes each composition fusion, improves the performance of drug effect, is heated to 70 DEG C, is incubated 25 minutes, obtains zymotic fluid;
(5)Lentinan, beta glucan, elemene and glycine betaine are added into zymotic fluid, is stirred to being completely dissolved, freeze-drying is extremely Water content is 8 ~ 10%, obtains mixed powder;
(6)Tilmicosin pre-mixing agent, florfenicol powder and Carbaspirin calcium powder are added into mixed powder, effect complements each other, promoted The performance of each composition drug effect, can provide nutrition, also can antibacterial sterilization, kill pathogenic microorganism, strengthen pig resistance against diseases, keep away Exempt to develop immunity to drugs antibiotic and antibiotic residue, improve the quality and mouthfeel of pork, be well mixed, obtain preventing and treating pig transmissible The medicine of pleuropneumonia;
(7)Vacuum packaging, inspection, obtains finished product.
The application method of the medicine of the preventing and treating porcine contagious pleuropneumonia, will prevent and treat the medicine of porcine contagious pleuropneumonia Pig feed is added, is well mixed, addition is the 0.3% of pig feed weight, the piglet at 2 weeks ~ 7 monthly ages, added within every 2 ~ 3 days Once, August and the pig after August age, addition in every 4 ~ 5 days is once.
Embodiment 2
A kind of medicine for preventing and treating porcine contagious pleuropneumonia, is made up of the raw material of following weight portion:Egg shell 73, tip or stalactite 57, Marmor serpentinatum 52, Tilmicosin pre-mixing agent 2.5, florfenicol powder 2.2, Carbaspirin calcium powder 2.2, asafoetide extract 1.7, peanut coat Extract 1.7, lentinan 0.25, beta glucan 0.24, elemene 0.08, glycine betaine 0.07, brewer's yeast 4.
Described egg shell, is the egg shell of generation after green shell hatching of breeding eggs.
Described asafoetide extract, asafoetide is crushed to, be placed in temperature for 40 ~ 45 DEG C, mass concentration be 1.4% it is edible Soaked 35 minutes in aqueous slkali, remove stink, cleaned with clear water, add 75 times of water of amount of asafoetide weight, heating is concentrated into volume It is original 1/20, crosses and filter precipitation, it is 4 ~ 6% that filtrate is dried to water content, obtains asafoetide extract.
Described peanut coat extract, peanut coat is fried to burnt odor, and the volume fraction for adding 65 times of amounts of peanut coat weight is 3.5% acetum, ultrasonic 45 minutes in 33kHz, heating is boiled, and it is original 1/15 to be concentrated into volume, is crossed and is filtered precipitation, It is 7 ~ 9% by freeze-drying to water content, obtains peanut coat extract.
Described lentinan, purity is 96 ~ 100%.
Described brewer's yeast, activated, viable count is 109~1010CFU/ml。
Preparation and application, with embodiment 1.
Embodiment 3
A kind of medicine for preventing and treating porcine contagious pleuropneumonia, is made up of the raw material of following weight portion:Egg shell 74, tip or stalactite 58, Marmor serpentinatum 53, Tilmicosin pre-mixing agent 2.6, florfenicol powder 2.3, Carbaspirin calcium powder 2.3, asafoetide extract 1.8, peanut coat Extract 1.8, lentinan 0.25, beta glucan 0.25, elemene 0.09, glycine betaine 0.08, brewer's yeast 5.
Described egg shell, is the egg shell of generation after green shell hatching of breeding eggs.
Described asafoetide extract, asafoetide is crushed to, be placed in temperature for 40 ~ 45 DEG C, mass concentration be 1.5% it is edible Soaked 40 minutes in aqueous slkali, remove stink, cleaned with clear water, add 80 times of water of amount of asafoetide weight, heating is concentrated into volume It is original 1/20, crosses and filter precipitation, it is 4 ~ 6% that filtrate is dried to water content, obtains asafoetide extract.
Described peanut coat extract, peanut coat is fried to burnt odor, and the volume fraction for adding 70 times of amounts of peanut coat weight is 4% acetum, ultrasonic 50 minutes in 34kHz, heating is boiled, and it is original 1/15 to be concentrated into volume, is crossed and is filtered precipitation, will Freeze-drying to water content is 7 ~ 9%, obtains peanut coat extract.
Described lentinan, purity is 96 ~ 100%.
Described brewer's yeast, activated, viable count is 109~1010CFU/ml。
Preparation and application, with embodiment 1.
Comparative example 1
Removal egg shell, tip or stalactite and marmor serpentinatum, remaining preparation and application, with embodiment 1.
Comparative example 2
Removal Tilmicosin pre-mixing agent, florfenicol powder and Carbaspirin calcium powder, remaining preparation and application, with embodiment 1.
Comparative example 2
Removal asafoetide extract and peanut coat extract, remaining preparation and application, with embodiment 1.
Comparative example 3
Removal lentinan, beta glucan, elemene and glycine betaine, remaining preparation and application, with embodiment 1.
Comparative example 4
Removal brewer's yeast and step(4)Fermentation, remaining preparation and application, with embodiment 1.
Comparative example 5
Removal step(1)Stir-fry, remaining preparation and application, with embodiment 1.
Comparative example 6
Removal step(2)Calcination, remaining preparation and application, with embodiment 1.
Comparative example 7
Removal step(4)Heating and insulation, remaining preparation and application, with embodiment 1.
Comparative example 8
The medicaments Ospen of existing conventional control porcine contagious pleuropneumonia.
The prevention effect of the medicine of embodiment and comparative example preventing and treating porcine contagious pleuropneumonia:
Healthy, the sizable 3 monthly age piglet 1100 of random selection, is randomly divided into 11 groups, every group 100, respectively to each group The piglet feeding group medicine, carry out feeding according to the application method of each medicine, free water, other management methods are identical, The tested time is 120 days, records the sick situation of piglet, and random selection is suitable with porcine contagious pleuropneumonia 2 days, symptom 10 monthly age pigs 1100, are randomly divided into 11 groups, every group 100, are treated with the medicine of embodiment and comparative example respectively, record The prevention effect of the medicine of the cure rate of porcine contagious pleuropneumonia, embodiment and comparative example preventing and treating porcine contagious pleuropneumonia is shown in Table 1.
Table 1:The prevention effect of the medicine of embodiment and comparative example preventing and treating porcine contagious pleuropneumonia
Project Pleuropneumonia rate/(%) Cure rate/(%) Brickpox rate/(%) Antibiotic
Embodiment 1 0 97 3 Do not detect
Embodiment 2 0 98 3 Do not detect
Embodiment 3 1 97 5 Do not detect
Comparative example 1 9 86 11 Do not detect
Comparative example 2 7 89 8 Do not detect
Comparative example 3 9 87 10 Do not detect
Comparative example 4 6 91 9 Do not detect
Comparative example 5 6 89 7 Do not detect
Comparative example 6 5 87 8 Do not detect
Comparative example 7 5 92 7 Do not detect
Comparative example 8 2 93 4 Detection
From the results shown in Table 1, the medicine of the preventing and treating porcine contagious pleuropneumonia of embodiment, porcine contagious pleuropneumonia rate Substantially low compared with comparative example with brickpox rate, porcine contagious pleuropneumonia cure rate is substantially high compared with comparative example, is not detected in pork residual The antibiotic for staying, illustrating the medicine of the preventing and treating porcine contagious pleuropneumonia of present invention offer has preferable prevention effect.

Claims (8)

1. it is a kind of prevent and treat porcine contagious pleuropneumonia medicine, it is characterised in that be made up of the raw material of following weight portion:Egg shell 72 ~ 74, tip or stalactite 56 ~ 58, marmor serpentinatum 51 ~ 53, Tilmicosin pre-mixing agent 2.4 ~ 2.6, florfenicol powder 2.1 ~ 2.3, kappa Woods calcium powder 2.1 ~ 2.3, asafoetide extract 1.6 ~ 1.8, peanut coat extract 1.6 ~ 1.8, lentinan 0.23 ~ 0.25, β-Portugal gather Sugar 0.23 ~ 0.25, elemene 0.07 ~ 0.09, glycine betaine 0.06 ~ 0.08, brewer's yeast 3 ~ 5.
2. it is according to claim 1 preventing and treating porcine contagious pleuropneumonia medicine, it is characterised in that described egg shell, It is the egg shell produced after green shell hatching of breeding eggs.
3. the medicine of preventing and treating porcine contagious pleuropneumonia according to claim 1, it is characterised in that described asafoetide is extracted Thing, asafoetide is crushed to, and is placed in temperature for 40 ~ 45 DEG C, mass concentration to soak 30 ~ 40 points in 1.3 ~ 1.5% edible alkali solution Clock, is cleaned with clear water, adds 70 ~ 80 times of water of amount of asafoetide weight, and it is original 1/20 that heating is concentrated into volume, cross filter it is heavy Form sediment, it is 4 ~ 6% that filtrate is dried to water content, obtains asafoetide extract.
4. it is according to claim 1 preventing and treating porcine contagious pleuropneumonia medicine, it is characterised in that described peanut coat is carried Take thing, peanut coat fried to burnt odor, add 60 ~ 70 times of volume fractions of amount of peanut coat weight for 3 ~ 4% acetum, in 32 ~ 34kHz ultrasounds 40 ~ 50 minutes, heating is boiled, and it is original 1/15 to be concentrated into volume, is crossed and is filtered precipitation, by freeze-drying to containing Water is 7 ~ 9%, obtains peanut coat extract.
5. it is according to claim 1 preventing and treating porcine contagious pleuropneumonia medicine, it is characterised in that described mushroom is more Sugar, purity is 96 ~ 100%.
6. it is according to claim 1 preventing and treating porcine contagious pleuropneumonia medicine, it is characterised in that described beer ferment Mother, activated, viable count is 109~1010CFU/ml。
7. described in a kind of claim 1 prevent and treat porcine contagious pleuropneumonia medicine preparation method, it is characterised in that including with Lower step:
(1)Egg shell is crushed, 80 ~ 90 DEG C is placed in and is stir-fried 10 ~ 15 minutes, obtain stir-fry egg-shell meal;
(2)Tip or stalactite and marmor serpentinatum are crushed to 80 ~ 100 mesh, in after 160 ~ 170 DEG C of calcinations 12 ~ 14 minutes, goose pipe are added immediately 3 ~ 4 times of temperature of amount of stone weight are 1 ~ 10 DEG C of water, are stirred, and naturally cool to room temperature, obtain stone flour slurry;
(3)Egg-shell meal will be fried and add stone flour slurry, be slowly added to the vinegar that 100 ~ 120 times of volume fractions of amount of egg shell weight are for 7 ~ 9% Acid solution, in 40 ~ 45 DEG C, 36 ~ 38kHz ultrasounds 20 ~ 25 minutes, heating boils that to be concentrated into volume be original 1/15, and filtering must be carried Take liquid;
(4)Asafoetide extract and peanut coat extract are added into extract solution, is well mixed, add brewer's yeast, it is quiet in 20 ~ 22 DEG C Put fermentation 3 ~ 4 days, be heated to 60 ~ 70 DEG C, be incubated 25 ~ 30 minutes, obtain zymotic fluid;
(5)Lentinan, beta glucan, elemene and glycine betaine are added into zymotic fluid, is stirred to being completely dissolved, freeze-drying is extremely Water content is 8 ~ 10%, obtains mixed powder;
(6)Tilmicosin pre-mixing agent, florfenicol powder and Carbaspirin calcium powder are added into mixed powder, is well mixed, pig must be prevented and treated The medicine of contagious pleuropneumonia;
(7)Vacuum packaging, inspection, obtains finished product.
8. the application method of the medicine of porcine contagious pleuropneumonia is prevented and treated described in a kind of any one of claim 1 ~ 7, and its feature exists In the medicine that will prevent and treat porcine contagious pleuropneumonia adds pig feed, is well mixed, and addition is pig feed weight The piglet at 0.3 ~ 0.4%, 2 weeks ~ 7 monthly ages, addition in every 2 ~ 3 days once, August and the pig after August age, addition in every 4 ~ 5 days is once.
CN201710029220.0A 2017-01-16 2017-01-16 A kind of medicine for preventing and treating porcine contagious pleuropneumonia Pending CN106860505A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201710029220.0A CN106860505A (en) 2017-01-16 2017-01-16 A kind of medicine for preventing and treating porcine contagious pleuropneumonia

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201710029220.0A CN106860505A (en) 2017-01-16 2017-01-16 A kind of medicine for preventing and treating porcine contagious pleuropneumonia

Publications (1)

Publication Number Publication Date
CN106860505A true CN106860505A (en) 2017-06-20

Family

ID=59157458

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201710029220.0A Pending CN106860505A (en) 2017-01-16 2017-01-16 A kind of medicine for preventing and treating porcine contagious pleuropneumonia

Country Status (1)

Country Link
CN (1) CN106860505A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114522144A (en) * 2022-01-13 2022-05-24 河南百草元兽药有限公司 Tilmicosin premix particles and preparation method thereof
CN114712313A (en) * 2021-11-26 2022-07-08 湖南佳锐思生物科技有限公司 Method for preparing efficient tilmicosin premix through adsorption crystallization and application of efficient tilmicosin premix

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103143019A (en) * 2013-03-15 2013-06-12 湖南泰谷生物科技股份有限公司 Compound preparation for treating porcine contagious pleuropneumonia and respiratory tract mixed infection and preparation method thereof

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103143019A (en) * 2013-03-15 2013-06-12 湖南泰谷生物科技股份有限公司 Compound preparation for treating porcine contagious pleuropneumonia and respiratory tract mixed infection and preparation method thereof

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
刘洪云,等: "《猪病防治技术手册》", 31 July 2009, 上海科学技术出版社 *
魏良思,等: "猪传染性胸膜肺炎的诊治案例", 《猪业观察》 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114712313A (en) * 2021-11-26 2022-07-08 湖南佳锐思生物科技有限公司 Method for preparing efficient tilmicosin premix through adsorption crystallization and application of efficient tilmicosin premix
CN114712313B (en) * 2021-11-26 2023-09-22 湖南湘农动物药业有限公司 Method for preparing efficient tilmicosin premix by adsorption crystallization and application thereof
CN114522144A (en) * 2022-01-13 2022-05-24 河南百草元兽药有限公司 Tilmicosin premix particles and preparation method thereof

Similar Documents

Publication Publication Date Title
CN102716164B (en) Echinacea extract and preparation method of echinacea extract
CN105380246A (en) Bone flavored Qi-regulating fresh and wet sweet potato vermicelli and preparation method thereof
JP2005151928A (en) Additive for feed
CN103330056A (en) Palm leaf pig feed and preparation method thereof
CN105076676B (en) The preparation method of additive of polypeptide feed
CN106860505A (en) A kind of medicine for preventing and treating porcine contagious pleuropneumonia
CN106615928A (en) Special feed for chicks
CN109717325A (en) A kind of egg feedstuff and preparation method thereof
CN106614278A (en) Method for controlling lamb diarrhoea
CN103783530B (en) A kind of composite fishbone hormone chewable tablet
CN107466964A (en) A kind of diseases prevention cultural method of live pig
CN105581044A (en) Meat rabbit feed and preparing method thereof
JP6675967B2 (en) Feed and its manufacturing method
CN106974131A (en) A kind of feed addictive for preventing and treating imperial black gill disease
KR101835862B1 (en) Process For Producing Detoxicated Sulfur
KR101729085B1 (en) Method for producing mushroom soondae improved savor and nutrition the mushroom soondae produced by the same
CN106721003A (en) Prevent and treat the feed addictive and preparation method of animal viral disease
CN106614376A (en) Prevention and control method of pullorum disease of chickens
KR102588124B1 (en) Method for manufacturing livestock feed additive using by-product of fermented omija sugar
CN109601758A (en) A kind of feed and preparation method thereof that quail immunity can be enhanced
CN107439472A (en) A kind of diseases prevention cultural method of live pig
CN106214778B (en) A kind of medicine for preventing and treating chicken coccidiasis and its preparation method and application
CN107183370A (en) A kind of feed addictive for preventing and treating sheep gastroenteritis
CN106387431A (en) Feed additive with effect of improving sow farrowing capacity
CN107047964A (en) A kind of Chinese medicine compounded fish feed and preparation method thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20170620

RJ01 Rejection of invention patent application after publication